Chevy Chase Trust Holdings, Inc. Abbott Laboratories Transaction History
Chevy Chase Trust Holdings, Inc.
- $35.7 Billion
- Q3 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 918,563 shares of ABT stock, worth $119 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
918,563
Previous 949,801
3.29%
Holding current value
$119 Million
Previous $129 Million
4.76%
% of portfolio
0.34%
Previous 0.38%
Shares
34 transactions
Others Institutions Holding ABT
# of Institutions
3,651Shares Held
1.38BCall Options Held
10.4MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...